Can DNA reveal the roots of a rare muscle disease?

NCT ID NCT06259071

Recruiting now Knowledge-focused Sponsor: George Washington University Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study aims to collect saliva samples from 1,000 people with a lab-confirmed diagnosis of MuSK myasthenia gravis, a rare autoimmune condition that weakens muscles. By comparing genetic information, researchers hope to identify variations linked to the disease. The findings could help explain what causes MuSK MG and guide the development of targeted treatments and biomarkers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could uncover genetic markers that explain why some people develop MuSK myasthenia gravis, potentially pointing toward targeted therapies.
What could go wrong: This is an observational genetic study, not a treatment trial, so it won't directly test any therapy. Finding meaningful genetic associations is uncertain and may require larger or different studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSK MG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myasthenia gravis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MUSK MG MUSK MYASTHENIA GRAVIS MYASTHENIA GRAVIS

Contacts and locations

Locations

George Washington University
RECRUITING

Washington D.C., District of Columbia, 20037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.